Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention

NCT02970253 is registered in ClinicalTrials.gov with ZOL as lead sponsor.

NCT NCT02970253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02970253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Anterior Approach (DAA) for Total Hip Arthroplasty (THA): Capsular Resection Versus Capsular Flap Retention
Lead sponsor
ZOL
Phase
Phase 1
Overall status
Completed
Start date
November 1, 2017
Completion date
December 31, 2019
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coxarthritis